VeriSIM Life

1 known investors

VeriSIM uses machine learning and computational simulation to accelerate drug development, replacing traditional trial-and-error experimentation with computational prediction to improve success rates and reduce animal testing. The company serves pharmaceutical partners and research institutions developing new medicines.

AI & Machine LearningBiotechDigital HealthMedical Devices